510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K161817Substantially Equivalent

Tina-quant Cystatin C Gen.2

Roche Diagnostics Operations (Rdo), Indianapolis IN / Special, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K161817 is the FDA 510(k) clearance record for Tina-quant Cystatin C Gen.2, a class II device, cleared for Roche Diagnostics Operations (Rdo) on under FDA product code NDY (Test, Cystatin C). FDA records list 14 510(k) clearances for Roche Diagnostics Operations (Rdo), from to . As of , FDA records show no recalls naming K161817.

Clearance record

Decision date
Received
(26 days to decision)
Product code
NDY Test, Cystatin C
Regulation
21 CFR 862.1225
Device class
Class II
Review panel
Clinical Chemistry
Applicant
Roche Diagnostics Operations (Rdo) 9115 Hague Rd., Indianapolis IN
510(k) summary
Summary PDF
Third party review
No

Clearances, product code NDY

Trailing 12 months

FDA records hold no clearances under product code NDY in the trailing twelve months.

FDA records show no clearances under product code NDY in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code NDY, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260